News

15
Feb

Diffusion of the updated “Standard legal clauses for information and consent forms for clinical trials”

Diffusion of the updated “Standard legal clauses for information and consent forms for clinical trials” CATALIS Québec is pleased to announce that the revised version of the “Standard legal clauses for information and consent forms for clinical trials” has been published by the ministry of health and social services (MSSS). The original legal clauses for consent forms, published in 2016

Read more

18
Jan

CATALIS Quebec announces the rolls out the 2nd phase of Nagano clinical trial evaluation management system synchronization in the Quebec’s health and social services institutions

CATALIS Quebec announces the rolls out the 2nd phase of Nagano clinical trial evaluation management system synchronization in the Quebec’s health and social services institutions Since 2010, majority of public institutions in Quebec’s health and social services network have gradually integrated the Nagano computer system, a platform that makes the administrative management of research projects, including clinical trials’ evaluation and

Read more

15
Jan

Announcement of the SOCRA Exam Bursary Recipients

Announcement of the SOCRA Exam Bursary Recipients  CATALIS Québec and the AQIIRC awarded their first joint bursary through a program to support the development of clinical research professionals in Quebec. Bursaries of up to CAN$350 each are being offered to clinical research professionals who have applied for the upcoming Society of Clinical Research Associates (SOCRA) CCRP® (Certified Clinical Research Professional)

Read more

22
Oct

World-Class Clinical Research Professionals

World-Class Clinical Research Professionals Since October 2019, Arnaud Villier has been the coordinator of start-up operations at the Unit for Innovative Therapies at Montréal’s CHUM Research Centre. “It is a job where you have to make sure that each of the steps that precede the start of a clinical trial in patients is completed in accordance with good clinical practice

Read more

2
Oct

CATALIS Québec and AQIIRC are launching a joint advanced training bursary program

CATALIS Québec and AQIIRC are launching a joint advanced training bursary program CATALIS Québec and the Association québécoise des infirmières et intervenants en recherche clinique (AQIIRC) are launching a joint advanced training bursary program to support the development of Quebec’s clinical research professionals. Bursaries in the amount of CAN$350 each are being offered to clinical research professionals registering for the

Read more

18
Jun

Message from the President

Message from the President I am delighted to be joining CATALIS Québec in order to contribute to the development of clinical research in Quebec and to foster solidarity between all industry stakeholders to improve the care of patients suffering from currently incurable diseases. As the new President, I would like to take this opportunity to report on the exceptional and

Read more

16
Jun

Appointment of Dr. Michael Sebag to CATALIS Québec’s Board

Appointment of Dr. Michael Sebag to CATALIS Québec’s Board CATALIS Québec is pleased to announce that Dr. Michael Sebag will be joining its Board of Directors as of June 18, 2020. A researcher at the McGill University Health Centre (MUHC) since 2009, Dr. Sebag has participated in an impressive number of clinical studies which provided access to innovative treatments to

Read more

9
Jun

Appointment of Jacques Hendlisz as CATALIS Québec’s New Executive President

Appointment of Jacques Hendlisz as CATALIS Québec’s New Executive President CATALIS Quebec is proud to welcome Mr. Jacques Hendlisz to the organization as its new Executive President, effective April 1, 2020. Mr. Hendlisz is widely recognized for his extensive experience in the management of both research and hospital facilities. He served as the Douglas Institute’s Director General from 1994 to

Read more

27
May

COVID-19 and clinical trials : point of view of Rémi Quirion

In light of the exceptional situation surrounding COVID-19, CATALIS interviewed clinical research leaders in Quebec to find out their perspectives on the crisis and to look for ways to adapt. The following statements detail the point of view of Dr. Rémi Quirion, Chief Scientist of Quebec.  Q. How do you think the COVID-19 pandemic will alter current and future clinical

Read more

25
May

COVID-19 and clinical trials : point of view of Alan Bernstein

COVID-19 and clinical trials : point of view of Alan Bernstein In light of the exceptional situation surrounding COVID-19, CATALIS interviewed clinical research leaders in Quebec to find out their perspectives on the crisis and to look for ways to adapt. The following statements detail the point of view of Alan Bernstein, President and CEO, CIFAR. Q. How do you

Read more